Artelo Biosciences Inc. (ARTL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Artelo Biosciences Inc.

    NASDAQ: ARTL · Real-Time Price · USD
    4.60
    0.25 (5.75%)
    At close: Sep 05, 2025, 3:59 PM
    4.57
    -0.65%
    After-hours: Sep 05, 2025, 07:56 PM EDT

    Artelo Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -10.11M -9.93M -10.29M -7.44M
    Interest Income
    		 n/a n/a 2K 2K
    Pretax Income
    		 -9.83M -9.29M -10.08M -7.44M
    Net Income
    		 -9.83M -9.29M -10.08M -7.44M
    Selling & General & Admin
    		 4.12M 4.23M 5.96M 4.6M
    Research & Development
    		 5.99M 5.7M 4.32M 2.84M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 10.11M 9.93M 10.29M 7.44M
    Interest Expense
    		 n/a n/a 5K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 10.11M 9.93M 10.29M 7.44M
    Income Tax Expense
    		 n/a n/a -209K -4K
    Shares Outstanding (Basic)
    		 3.22M 2.96M 472K 207.5K
    Shares Outstanding (Diluted)
    		 3.22M 2.96M 472.17K 207.5K
    EPS (Basic)
    		 -3.05 -3.14 -3.49 -5.97
    EPS (Diluted)
    		 -3.05 -3.14 -3.49 -5.97
    EBITDA
    		 -10.11M -9.93M -10.29M -7.44M
    EBIT
    		 -9.83M -9.29M -10.29M -7.44M
    Depreciation & Amortization
    		 n/a n/a 2K -2K

    Add to Watchlist